8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (May 3, 2018)

Filed May 3, 2018For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on May 3, 2018, to announce its financial results for the quarter ended March 31, 2018. The report primarily consists of a press release furnished as an exhibit, detailing the company's operational and financial performance during the period. Investors should refer to this press release for specific details on revenue, expenses, earnings, and any forward-looking statements made by management regarding the company's pipeline and strategic outlook. While this 8-K doesn't contain extensive new financial data directly within the form itself, it serves as the official channel for disseminating the company's quarterly performance. The information provided is crucial for assessing Alnylam's progress, particularly concerning its development of RNAi therapeutics, and for understanding its financial health as it advances its drug candidates through clinical trials and towards potential commercialization.

Key Highlights

  • 1Alnylam Pharmaceuticals announced its first-quarter 2018 financial results on May 3, 2018.
  • 2The 8-K filing includes a press release (Exhibit 99.1) detailing these results.
  • 3Investors need to review the furnished press release for specific financial and operational data.
  • 4The filing is relevant for understanding the company's financial condition as of March 31, 2018.
  • 5This report signals an update on the company's performance and potential progress in its drug development pipeline.
  • 6The information furnished is not considered 'filed' for certain regulatory purposes, but is material for investor analysis.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and disseminate Alnylam Pharmaceuticals' financial results for the quarter ended March 31, 2018, through a furnished press release.

The detailed financial results and commentary are contained within the press release furnished as Exhibit 99.1 to this Form 8-K.

No, this 8-K filing primarily furnishes a press release. Audited financial statements are typically filed in the quarterly (10-Q) or annual (10-K) reports.

When information is furnished under Item 2.02 of an 8-K, it means the company is providing it to the SEC for public disclosure but is not subject to the same liability provisions under Section 18 of the Exchange Act as if it were 'filed'. However, it is still considered material information for investors.